Tivic Health Systems, Inc.
TIVC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $2 | $1 |
| % Growth | -33.7% | -36.1% | 57.8% | – |
| Cost of Goods Sold | $1 | $1 | $2 | $1 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 0.3% | 24.4% | 16.3% | -11.1% |
| R&D Expenses | $1 | $2 | $2 | $1 |
| G&A Expenses | $3 | $5 | $6 | $3 |
| SG&A Expenses | $4 | $7 | $9 | $5 |
| Sales & Mktg Exp. | $1 | $2 | $3 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $9 | $10 | $6 |
| Operating Income | -$6 | -$8 | -$10 | -$6 |
| % Margin | -725.8% | -701.1% | -548.8% | -483% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$3 |
| Pre-Tax Income | -$6 | -$8 | -$10 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$8 | -$10 | -$8 |
| % Margin | -725% | -701% | -548.7% | -728.5% |
| EPS | -19.67 | -176.72 | -104.37 | -243.16 |
| % Growth | 88.9% | -69.3% | 57.1% | – |
| EPS Diluted | -19.67 | -176.72 | -104.37 | -243.15 |
| Weighted Avg Shares Out | 287 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 287 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $2 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$8 | -$10 | -$7 |
| % Margin | -680.6% | -685.5% | -539.3% | -570.1% |